Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis

SD Stojanović, J Fiedler, J Bauersachs… - European Heart …, 2020 - academic.oup.com
Inflammation is a hallmark and potent driver of pathological vascular remodelling in
atherosclerosis. However, current anti-inflammatory therapeutic strategies have shown …

Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis.

SD Stojanović, J Fiedler, J Bauersachs… - European Heart …, 2020 - search.ebscohost.com
Inflammation is a hallmark and potent driver of pathological vascular remodelling in
atherosclerosis. However, current anti-inflammatory therapeutic strategies have shown …

[HTML][HTML] Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis

SD Stojanović, J Fiedler, J Bauersachs… - European Heart …, 2020 - ncbi.nlm.nih.gov
Inflammation is a hallmark and potent driver of pathological vascular remodelling in
atherosclerosis. However, current anti-inflammatory therapeutic strategies have shown …

[PDF][PDF] Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis

SD Stojanović, J Fiedler, J Bauersachs… - European Heart …, 2020 - academic.oup.com
Inflammation is a hallmark and potent driver of pathological vascular remodelling in
atherosclerosis. However, current anti-inflammatory therapeutic strategies have shown …

Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis

SD Stojanović, J Fiedler, J Bauersachs… - European heart …, 2020 - pubmed.ncbi.nlm.nih.gov
Inflammation is a hallmark and potent driver of pathological vascular remodelling in
atherosclerosis. However, current anti-inflammatory therapeutic strategies have shown …

Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis.

SD Stojanović, J Fiedler, J Bauersachs… - European Heart …, 2020 - europepmc.org
Inflammation is a hallmark and potent driver of pathological vascular remodelling in
atherosclerosis. However, current anti-inflammatory therapeutic strategies have shown …

[PDF][PDF] Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis

SD Stojanovic, J Fiedler, J Bauersachs… - European Heart …, 2020 - pdfs.semanticscholar.org
Inflammation is a critical driver of atherosclerosis and an independent risk factor for
myocardial infarction and cardiovascular death. 1 The Canakinumab Anti-inflammatory …